ARCHES: A Multinational, Phase 3, Randomized, Double-blind, Placebo-controlled Efficacy and Safety Study of Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Patients with Metastatic Hormone Sensitive Prostate Cancer (mHSPC)

Project: Research

Project Description

NMA Reference Number: HREC/16/HAWKE/66
SSA Reference Number: SSA/17/MonH/67
Monash Health HREC Ref: RES-17-0000098X
StatusActive
Effective start/end date28/02/1927/02/24